MedTrace Logo

VergenixTM Flowable Gel in Patients With Lower Limb Ulcers

NCT02598180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-02-20

No results posted yet for this study

Summary

Vergenix Flowable Gel is indicated for the management of acute and chronic wounds

Conditions

  • Lower Limb Ulcers

Interventions

DEVICE

VergenixTM Flowable Gel

The VergenixTM Flowable Gel is supplied as powder contained in a syringe that will be hydrated with saline.

Sponsors & Collaborators

  • Collplant

    lead INDUSTRY

Principal Investigators

  • Eran Tamir, MD · Maccabi Health Care

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-25
Primary Completion
2015-11-02
Completion
2015-11-02

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02598180 on ClinicalTrials.gov